Global Market Insights Highlights Top 4 Stroke Management Market Trends Through 2027

February 16, 2022 — The increasing incidences of cardiovascular diseases due to unhealthy eating habits, increased consumption of alcohol, high rates of smoking, and sedentary lifestyles are projected to have a significant impact on global stroke management. According to Centers for Disease Control estimates, every year, more than 795,000 Americans suffer from stroke. A person succumbs to death every 4 minutes in the U.S. due to stroke. These statistics emphasize the intrinsic need for stroke management solutions and services.

Propelled by advancements, the global stroke management market is poised to account for a valuation of $48.5 billion USD over the span of 2021-2027. The rise can be attributed to technological developments that have led to novel introductions in the space. As an example, Medtronic and Apollo Hospitals recently collaborated to integrate an artificial intelligence (AI) platform in stroke management that is expected to reduce the diagnosis period.

Four Stroke Management Trends Expected Through 2027

(1) Increased transient ischemic attack prevalence in the elderly population

Transient ischemic attack, a ministroke caused due to temporary disruption in the blood supply to the part of the brain, is now taking a toll across various economies. Nearly 15% of all strokes are foretold by a transient ischemic attack, considered to be extremely common in the geriatric or elderly population.

(2) Heightened adoption of stroke diagnostic devices

With the rising prevalence of strokes worldwide, the demand for stroke diagnostic devices has risen profoundly. The stroke diagnostic devices segment is projected to expand at a CAGR of 5.9% through 2027.

Of the many diagnostic devices available in the market, magnetic resonance imaging (MRI) is offering several developments in diagnostic techniques. These advancements streamline the imaging workflow and offer faster scanning. One of the recent breakthroughs was achieved by GE Healthcare wherein the company announced receiving the USFDA approval for its MAGnetic resonance image Compilation (MAGiC) software. The product has been designed to aid in carrying out the diagnosis and management of acute ischemic stroke.

(3) Huge patient ingress in diagnostic centers

Patient interest in diagnostic centers for stroke management is a result of these centers' ability to offer effective medical proficiency, and facilities under the supervision of healthcare and medical professionals. In addition, there is an ascending demand for stroke management devices in ischemic, emergency, and hemorrhagic strokes.

(4) Alarming stroke concerns in Asia Pacific economies

The burden of stroke is expanding in the Asia Pacific economies with unhealthy lifestyle conditions and food consumption being the prominent factors. The prevalence of stroke in China is twice more than in any other country. Furthermore, as per the OECD statistics, ischemic stroke was touted as one of the major causes of death in the region in 2016, recording a death rate of 25.2% in the Western Pacific region and 34.8% deaths in Southeast Asia region. This allows the region to be highly inclined towards the adoption of stroke management devices and solutions.

The APAC stroke management market is claimed to depict a CAGR of 6.6% through 2027, fueled by the initiatives undertaken by various central governments in the development of healthcare facilities.

On the whole, the rising frequency of strokes and other cardiovascular diseases worldwide is projected to have an enormous impact on the overall stroke management market in the near future.

Learn more about Global Market Insights at https://www.gminsights.com/